东亚药业：关于“东亚转债”预计满足转股价格修正条件的提示性公告

Group 1 - The core point of the article is that East Asia Pharmaceutical announced that its stock price has been below 90% of the current conversion price for 10 trading days, which may trigger a downward adjustment of the conversion price for its convertible bonds [2] - The specific conversion price mentioned is 18.25 yuan per share, and if the stock price continues to remain below this threshold, the company will hold a board meeting to decide on the adjustment [2] - The company emphasizes the importance of investors being aware of the potential investment risks associated with this situation [2]